![](/img/cover-not-exists.png)
A multiâinstitutional phase 2 trial of regorafenib in refractory advanced biliary tract cancer
Kim, Richard D., Sanoff, Hanna K., Poklepovic, Andrew S., Soares, Heloisa, Kim, Jongphil, Lyu, Jing, Liu, Yingmiao, Nixon, Andrew B., Kim, Dae WonJournal:
Cancer
DOI:
10.1002/cncr.32964
Date:
May, 2020
File:
PDF, 330 KB
2020